Aptevo Therapeutics Inc (NASDAQ:APVO) price on Wednesday, October 23, fall -22.14% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $0.28.
A look at the stock’s price movement, the close in the last trading session was $0.35, moving within a range at $0.253 and $0.32. The beta value (5-Year monthly) was 5.146. Turning to its 52-week performance, $15.31 and $0.14 were the 52-week high and 52-week low respectively. Overall, APVO moved 58.67% over the past month.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Aptevo Therapeutics Inc’s market cap currently stands at around $2.59 million, with investors looking forward to this quarter’s earnings report slated for in November.
Turning to the stock’s technical picture we see that short term indicators suggest on average that APVO is a 50% Sell. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
APVO’s current price about 51.31% and 2.67% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 59.04, while 7-day volatility ratio is 53.10% and 19.09% in the 30-day chart. Further, Aptevo Therapeutics Inc (APVO) has a beta value of 5.17, and an average true range (ATR) of 0.06.
If we refocus on Aptevo Therapeutics Inc (NASDAQ:APVO), historical trading data shows that trading volumes averaged 30.84 over the past 10 days and 5.58 million over the past 3 months. The company’s latest data on shares outstanding shows there are 9.42 million shares.
The 0.06% of Aptevo Therapeutics Inc’s shares are in the hands of company insiders while institutional holders own 20.85% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 58354.0 on 2024-09-30, giving us a short ratio of 0.02. The data shows that as of 2024-09-30 short interest in Aptevo Therapeutics Inc (APVO) stood at 43.0 of shares outstanding, with shares short falling to 61430.0 registered in 2024-08-30. Current price change has pushed the stock -96.54% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the APVO stock continues to rise going into the next quarter.
